The global vascular graft market is estimated to value over USD 3.1 billion by 2026 end and surpass a CAGR of over 6.1% from the forecast period 2019-2026. Rising cases of cardiac diseases, diabetes, vascular occlusions and end stage renal disease are driving the global vascular graft market growth. Unhealthy eating habits and changing lifestyle are also fueling the growth of the market. Unhealthy eating habits have resulted in increasing of diabetes patient. According to International Diabetes Federation, the number of people suffering from diabetes is expected to reach 629 million by 2045 end. Such high growth in cases of diabetes is expected to positively influence the market. The market is bifurcated into by product, by application, by raw material and by region. In terms of product, endovascular stent grafts are expected to control the growth of the market. Increasing prevalence of hardening of arteries and renal failure coupled with growing number of abdominal aortic aneurysm is driving the demand of endovascular stent grafts. Technological advancements have resulted in production of efficient product such as Nellix, as a result increasing the global vascular graft market size. On the basis of application, cardiac aneurysms are expected to control the growth of the market. The introduction of advance tissue engineered grafts coupled with increasing prevalence of high blood pressure has resulted in growth of the segment. Advancement of novel prosthetic grafts with enhanced efficiency and porosity is driving the demand of the product. Growing number of treatment failures for cardiovascular diseases is also positively influencing the demand for cardiac aneurysms product. Based on raw materials, PTFE is expected to show notable growth owing to its various usage. PTFE are mainly utilized for ischemic heart diseases for patient needed to undergo aorta coronary bypass graft surgeries. It's also utilized for peripheral bypasses procedures. Technological advancements in the form of advanced argon plasma-treated PTFE is expected to increase PTFE thus expanding the vascular graft market size. In terms of region, North America is the global leader of the market. Rising cases of chronic kidney diseases and increasing prevalence of diabetes is boosting the presence of the market in the region. Presence of advanced healthcare infrastructure alongside presence of prominent players is bolstering the market in the region. Asia-Pacific region is expected to show exponential growth owing to increasing cases of diabetes and cardiovascular diseases in the region. Improving healthcare infrastructure alongside increasing funding for research and development activities is stimulating the market in the region. Rising geriatric population in countries like China and Japan is positively influencing the market in the region. Key players of the market are Cardinal Health Inc,m LeMaitre Vascular, Inc., Medtronic plx, W.L Gore & Associates, Inc., Jotec GmbH, Nano Endoluminal, Lombard Medical,Inc., Cardiatis S.A, B.Braun Melsungen AG and Endologix Inc. Global Vascular Graft Market Segmentation By Product Hemodialysis Access Endovascular Stent Peripheral By Application Cardiac Aneurysms Kidney Failure Vascular Occlusion By Raw Materials Polyester-based Polytetrafluoroethylene-based Polyurethane based Biological Materials-based - Human Saphenous and Umbilical Veins - Tissue Engineered Materials By Region North America Europe Asia Pacific Latin America Rest of the World Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth Prospects SWOT Analysis Key Trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global vascular graft market by product, by application, by raw materials and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities) To forecast and evaluate micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and the rest of the world To record, evaluate and analyse competitive landscape mapping- technological advancements, product launches, expansions and mergers Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com
The global vascular graft market is estimated to value over USD 3.1 billion by 2026 end and surpass a CAGR of over 6.1% from the forecast period 2019-2026.
Rising cases of cardiac diseases, diabetes, vascular occlusions and end stage renal disease are driving the global vascular graft market growth. Unhealthy eating habits and changing lifestyle are also fueling the growth of the market. Unhealthy eating habits have resulted in increasing of diabetes patient. According to International Diabetes Federation, the number of people suffering from diabetes is expected to reach 629 million by 2045 end. Such high growth in cases of diabetes is expected to positively influence the market.
The market is bifurcated into by product, by application, by raw material and by region. In terms of product, endovascular stent grafts are expected to control the growth of the market. Increasing prevalence of hardening of arteries and renal failure coupled with growing number of abdominal aortic aneurysm is driving the demand of endovascular stent grafts. Technological advancements have resulted in production of efficient product such as Nellix, as a result increasing the global vascular graft market size.
On the basis of application, cardiac aneurysms are expected to control the growth of the market. The introduction of advance tissue engineered grafts coupled with increasing prevalence of high blood pressure has resulted in growth of the segment. Advancement of novel prosthetic grafts with enhanced efficiency and porosity is driving the demand of the product. Growing number of treatment failures for cardiovascular diseases is also positively influencing the demand for cardiac aneurysms product.
Based on raw materials, PTFE is expected to show notable growth owing to its various usage. PTFE are mainly utilized for ischemic heart diseases for patient needed to undergo aorta coronary bypass graft surgeries. It's also utilized for peripheral bypasses procedures. Technological advancements in the form of advanced argon plasma-treated PTFE is expected to increase PTFE thus expanding the vascular graft market size.
In terms of region, North America is the global leader of the market. Rising cases of chronic kidney diseases and increasing prevalence of diabetes is boosting the presence of the market in the region. Presence of advanced healthcare infrastructure alongside presence of prominent players is bolstering the market in the region.
Asia-Pacific region is expected to show exponential growth owing to increasing cases of diabetes and cardiovascular diseases in the region. Improving healthcare infrastructure alongside increasing funding for research and development activities is stimulating the market in the region. Rising geriatric population in countries like China and Japan is positively influencing the market in the region.
Key players of the market are Cardinal Health Inc,m LeMaitre Vascular, Inc., Medtronic plx, W.L Gore & Associates, Inc., Jotec GmbH, Nano Endoluminal, Lombard Medical,Inc., Cardiatis S.A, B.Braun Melsungen AG and Endologix Inc.
Global Vascular Graft Market Segmentation
By Product
By Application
By Raw Materials
- Human Saphenous and Umbilical Veins
- Tissue Engineered Materials
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com
OR